BARTOLINI, ALESSANDRO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 14.608
NA - Nord America 7.671
AS - Asia 988
AF - Africa 33
OC - Oceania 2
SA - Sud America 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 23.305
Salva come PNG Salva come JPEG
Nazione #
PL - Polonia 11.342
US - Stati Uniti d'America 7.643
SE - Svezia 729
IE - Irlanda 665
IT - Italia 515
UA - Ucraina 494
HK - Hong Kong 329
DE - Germania 320
VN - Vietnam 241
GB - Regno Unito 234
FI - Finlandia 176
CN - Cina 162
KR - Corea 90
TR - Turchia 65
FR - Francia 40
JO - Giordania 40
SC - Seychelles 33
CA - Canada 25
SG - Singapore 22
CH - Svizzera 21
BE - Belgio 20
JP - Giappone 18
NL - Olanda 16
RU - Federazione Russa 11
IN - India 8
RO - Romania 6
HR - Croazia 4
ES - Italia 3
IR - Iran 3
TW - Taiwan 3
AR - Argentina 2
AT - Austria 2
BG - Bulgaria 2
CZ - Repubblica Ceca 2
MX - Messico 2
NZ - Nuova Zelanda 2
AF - Afghanistan, Repubblica islamica di 1
AM - Armenia 1
EE - Estonia 1
EU - Europa 1
GR - Grecia 1
IL - Israele 1
LB - Libano 1
LT - Lituania 1
LV - Lettonia 1
MD - Moldavia 1
PH - Filippine 1
PK - Pakistan 1
PR - Porto Rico 1
RS - Serbia 1
UZ - Uzbekistan 1
Totale 23.305
Salva come PNG Salva come JPEG
Città #
Warsaw 11.341
Fairfield 1.091
Ashburn 813
Jacksonville 743
Dublin 665
Chandler 607
Woodbridge 505
Seattle 470
Cambridge 456
Wilmington 407
Houston 376
Dong Ket 223
Hong Kong 200
Altamura 170
Ann Arbor 165
Princeton 165
Lawrence 137
Boardman 133
Boston 111
Beijing 97
San Diego 84
Seongnam 73
Medford 71
Phoenix 69
Izmir 61
Falls Church 55
Buffalo 45
Shanghai 42
Washington 40
Milan 35
Florence 32
Frankfurt Am Main 26
Norwalk 26
Auburn Hills 25
Hillsboro 24
West Jordan 24
New York 21
Bern 20
Brussels 20
Los Angeles 20
Verona 19
Andover 18
Dearborn 18
Guangzhou 16
Kent 15
Tokyo 13
Toronto 12
London 11
Philadelphia 11
Tappahannock 9
Mcallen 8
Ottawa 8
Saint Louis 8
Bremen 7
Seoul 7
Redwood City 6
Lappeenranta 5
Moncalieri 5
Redmond 5
Amsterdam 4
Easton 4
Kilburn 4
Palermo 4
San Jose 4
Sesto Fiorentino 4
Acton 3
Bucharest 3
Central 3
Chicago 3
Fano 3
Frankfurt am Main 3
Fuzhou 3
Genoa 3
Helsinki 3
Monza 3
Pune 3
Salerno 3
San Martino Buon Albergo 3
Sassano 3
Singapore 3
Turate 3
Atlanta 2
Bengaluru 2
Berlin 2
Bitonto 2
Buccinasco 2
Buenos Aires 2
Casnate Con Bernate 2
Catania 2
Cormano 2
Dallas 2
Edinburgh 2
Giugliano in Campania 2
Guadalajara 2
Hsinchu 2
Islington 2
Kanazawa 2
Laurel 2
Luisago 2
Lyon 2
Totale 19.999
Salva come PNG Salva come JPEG
Nome #
Antinociceptive property of the nicotinic agonist AG4 in rodents 431
M1 receptor activation is a requirement for arecoline analgesia. 319
DM235 (sunifiram): a novel nootropic with potential as a cognitive enhancer 305
Molecular simplification of 1,4-diazabicyclo[4.3.0]nonan-9-ones gives piperazine derivatives that maintain high nootropic activity 280
The novel nootropic compound DM232 (UNIFIRAM) ameliorates memory impairment in mice and rats 264
AMITRIPTYLINE AND CLOMIPRAMINE ACTIVATE GI-PROTEIN SIGNALING PATHWAY IN THE INDUCTION OF ANALGESIA 260
4-Aminopiperidine derivatives as a new class of potent cognition enhancing drugs 254
AG-4:A NICOTINIC AGONIST ENDOWED WITH ANTIAMNESIC PROPERTIES 251
PIRACETAM AND ANIRACETAM ANTAGONISM OF CENTRALLY ACTIVE DRUG-INDUCED ANTINOCICEPTION 250
A Prolonged Protein Kinase C-Mediated, Opioid-Related Antinociceptive Effect of St John's Wort in Mice 246
Supraspinal role of protein kinase C in oxaliplatin-induced neuropathy in rat. 241
Loss of muscarinic antinociception by antisense inhibition of M1 receptors. 239
NO DEVELOPMENT OF TOLERANCE TO ANALGESIA BY REPEATED ADMINISTRATION OF H1 ANTAGONISTS 238
S(-)ET126: a potent and selective M1 antagonist in vitro and in vivo 238
5-HT1A AGONISTS INDUCE CENTRAL CHOLINERGIC ANTINOCICEPTION 237
LOCAL ANAESTHETIC ACTIVITY OF (+) AND (-) MENTHOL 234
Antisense knockdowns of M1 receptors induces transient anterograde amnesia in mice 234
EFFECT OF PERTUSSIS TOXIN ON BACLOFEN-AND DIPHENHYDRAMINE- INDUCED AMNESIA 232
HYPOFUNCTIONALITY OF GI PROTEINS AS AETIOPHATOGENETIC MECHANISM FOR MIGRAINE AND CLUSTER HEADACHE 232
EFFECT OF POTASSIUM CHANNEL MODULATORS IN MOUSE FORCED SWIMMING TEST 231
Prochlorperazine induces central antinociception mediated by the muscarinic system. 231
A gene-specific cerebral types 1, 2, and 3 RyR protein knockdown induces an antidepressant-like effect in mice. 230
Role of intracellular calcium in acute thermal pain perception 230
Acetyl-l-Carnitine in the Management of Pain During Methadone Withdrawal Syndrome. 230
THE ROLE OF POTASSIUM CHANNELS IN ANTIHISTAMINE ANALGESIA 230
Acetyl-L-carnitine requires phospholipase C-IP3 pathway activation to induce antinociception. 229
Memory facilitation with atropine: a paradoxical effect 229
[(3-chlorophenyl)piperazinylpropyl]pyridazinones and analogues as potent antinociceptive agents 229
ROLE OF 5-HT1A RECEPTORS IN A MOUSE PASSIVE AVOIDANCE PARADIGM 228
ANTIAMNESIC ACTIVITY OF THE NICOTINIC AGONIST DBO-83 IN MICE 227
Central muscarinic antinociception induced by ET-142 and SS-20 in rodents 226
Alpha-2 agonist-induced memory impairment is mediated by the alpha-2A-adrenoceptor subtype. 226
IMPROVEMENT OF COGNITIVE FUNCTIONS BY THE ACETYLCHOLINE RELEASER SM21 224
Endogenous morphine modulates acute thermonociception in mice. 224
Different involvement of type 1, 2, and 3 ryanodine receptors in memory processes. 224
ANTINOCICEPTIVE PROFILE OF THE NATURAL CHOLINESTERASE INHIBITOR HUPERZINE A 223
Influence of potassium channel modulators on cognitive processes in mice 223
Blockade of intracellular calcium release induces an antidepressant-like effect in the mouse forced swimming test. 222
Pro-cognitive activity induced in the rat by low doses of R-(+)-hyoscyamine. 222
Type 1 and type 3 ryanodine receptors are selectively involved in muscarinic antinociception in mice: An antisense study. 220
Effect of K+ channel modulation on mouse feeding behaviour 219
Mono- and disubstituted-3,8-diazabicyclo[3.2.1]octane derivatives as analgesics structurally related to epibatidine: synthesis, activity, and modeling. 219
Inactivation of Gi proteins induces an antidepressant-like effect in the mouse forced-swimming test. 219
An antidepressant behaviour in mice carrying a gene-specific InsP3R1, InsP3R2 and InsP3R3 protein knockdown. 218
Central cholinergic antinociception induced by 5HT4 agonists: BIMU 1 and BIMU 8 218
3-ALFA-TROPANYL 2-(4-Cl-PHENOXY)BUTIRATE (SM21): A REVIEW OF THE PHARMACOLOGICAL PROFILE OF A NOVEL ENHANCER OF CHOLINERGIC TRANSMISSION. 216
Involvement of potassium channels in amitriptyline and clomipramine analgesia. 216
In vitro characterization of a novel, potent and selective M3 antagonist 216
Role of Gi proteins in the antidepressant-like effect of amitriptyline and clomipramine. 216
ANTIHISTAMINE ANTINOCICEPTION IS MEDIATED BY GI-PROTEIN ACTIVATION 216
PHARMACOLOGICAL CHARACTERIZATION OF THE NOVEL ACH RELEASER A-TROPANYL 2-(4-BROMOPHENYL)PROPIONATE (PG-9). 216
KV1.1 CHANNEL ANTISENSE ATTENUATES LEARNING AND MODULATION OF DENTATE POLYSIALYLATED NCAM 215
Knockdown of the type 2 and 3 inositol 1,4,5-trisphosphate receptors suppresses muscarinic antinociception in mice. 215
Diphenhydramine-induced amnesia is mediated by Gi-protein activation. 215
Presynaptic Cholinergic Modulators as Potent Cognition Enhancers and Analgesic Drugs. 2. 2-Phenoxy-, 2-(phenylthio)- and 2-(phenylamino)alkanoic Acid Esters 213
Ryanodine receptors are involved in muscarinic antinociception in mice. 213
Antinociceptive profile of SM21: a novel analgesic with a presynaptic cholinergic mechanism of action 209
Caffeine induces central cholinergic analgesia. 206
ANTINOCICEPTIVE EFFECT OF R-(+)-HYOSCYAMMINE ON THE CONJUNCTIVAL REFLEX TEST IN RABBITS 203
ANTINOCICEPTION INDUCED BY SM32 DEPENDS ON CENTRAL CHOLINERGIC MECHANISM 201
H1-receptor stimulation induces hyperalgesia through activation of the phospholipase C-PKC pathway. 201
Analgesic and antineuropathic drugs acting through central cholinergic mechanisms 201
Neuropathy-induced apoptosis: Protective effect of physostigmine 200
Effect of pertussis toxin on morphine, diphenhydramine, baclofen, clomipramine and physostigmine antinociception. 199
Local anaesthetic activity of beta-caryophyllene. 199
ACETYL-L-CARNITINE INDUCES MUSCARINIC ANTINOCICEPTION IN MICE AND RATS 195
Design, synthesis and preliminary pharmacological evaluation of 1,4-diazabicyclo[4.3.0]nonan-9-ones as a new class of highly potent nootropic drugs. 193
ANTIAMNESIC EFFECT OF THE TWO NOVEL K-OPIOID AGONISTS, VA-100 AND VA-101, IN THE MOUSE PASSIVE AVOIDANCE TEST 193
Are the contractions of rabbit peripheral lung, guinea-pig gall-bladder and guinea-pig uterus mediated by identical receptor subtype? 193
Alpha-2 agonits induce amnesia through activation of the Gi-protein signalling pathway. 192
Memory facilitation and stimulation of endogenous nerve growth factor synthesis by the ACh releaser PG9 190
Reversible antisense inhibition of Shaker-like Kv1.1 potassium channel expression impairs associative memory in mouse and rat 189
THE CENTRAL CHOLINERGIC SYSTEM HAS A ROLE IN THE ANTINOCICEPTION INDUCED IN RODENTS AND GUINEA-PIGS BY THE ANTIMIGRAINE DRUG SUMATRIPTAN 188
ROLE OF 5-HT4 RECEPTORS IN THE MOUSE PASSIVE AVOIDANCE TEST 187
Baclofen antinociception is prevented by ICV injection of pertussis toxin and by an aODN to the mKv1.1 potassium channel.. 187
Blockade of clomipramine and amitriptyline analgesia by an antisense oligonucleotide to mKv1.1, a mouse Shaker-like potassium channe 186
PHARMACOLOGICAL IDENTIFICATION OF SM-21, THE NOVEL SIGMA2 ANTAGONIST 186
A REDUCED FUNCTIONALITY OF GI PROTEINS AS A POSSIBLE CAUSE FOR FIBROMYALGIA 185
Binding Profiles of a Series of 2-Arylpropionic Acid Esters on Cloned Human Muscarinic Receptors Subtypes (m1-m5) and Their Relationship to Nootropic Activity 183
CENTRAL CHOLINERGIC CHALLENGING OF MIGRAINE BY TESTING SECOND-GENERATION ANTICHOLINESTERASE DRUG 183
Role of potassium channels in the antinociception induced by agonists of alpha2-adrenoceptors 180
Antinociceptive and antiamnesic properties of the presynaptic amplifier PG-9 179
Involvement of central cholinergic system in antinociception induced by sumatriptan in mouse. 179
ANTINOCICEPTION INDUCED BY AMITRIPTYLINE AND IMIPRAMINE IS MEDIATED BY A2A-ADRENOCEPTORS 177
Differential prevention of morphine amnesia by antisense oligodeoxynucleotides directed against Gi-protein a subunits. 169
Antagonism by piracetam of baclofen antinociception 167
Chiral synthesis and pharmacological evaluation of the enantiomers of SM32, a new analgesic and cognition-enhancing agent. 108
Structure-affinity relationships of a unique nicotinic ligand: N1-dimethyl-N4-phenylpiperazinium iodide (DMPP) 104
Gi/o proteins: expression for direct activation enquiry 100
Synthesis and Enantioselectivity of the Enantiomers of PG9 and SM21, New Potent Analgesic and Cognition-Enhancing Drugs 100
DIFFERENTIAL ANALGESIC ACTIVITY OF THE ENANTIOMERS OF ATROPINE DERIVATIVES DOES NOT CORRELATE WITH THEIR MUSCARINIC SUBTYPE SELECTIVITY 99
ANTIAMNESIC ACTIVITY OF METOCLOPRAMIDE, CISAPRIDE AND SR-17 IN THE MOUSE PASSIVE AVOIDANCE TEST 95
PRESYNAPTIC AUTO- AND HETERO-RECEPTORS IN THE CHOLINERGIC REGULATION OF PAIN 95
Antidepressant-like effect of artemin in mice: a mechanism for acetyl-l-carnitine activity on depression 94
INVESTIGATION INTO THE ROLE OF HISTAMINE RECEPTORS IN RODENT ANTINOCICEPTION 93
MENTHOL: A NATURAL ANALGESIC COMPOUND 92
ROLE OF MUSCARINIC RECEPTOR SUBTYPES IN CENTRAL ANTINOCICEPTION 90
Presynaptic Cholinergic Modulators as Potent Cognition Enhancers and Analgesic Drugs. 1. Tropic and 2-Phenylpropionic Acid Esters 89
S-(-)-ET126: a potent and selective M1 antagonist 88
REDUCED FLEXIBILITY ANALOGS OF ANALGESIC AND COGNITION-ENHANCING A-TROPANYL ESTERS 87
Totale 20.237
Salva come PNG Salva come JPEG
Categoria #
all - tutte 45.976
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 45.976
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20191.380 0 0 0 0 0 0 0 0 0 0 835 545
2019/20205.325 431 711 238 428 606 533 412 673 387 306 552 48
2020/20213.911 314 407 181 489 205 474 206 337 277 550 82 389
2021/20221.296 29 155 106 36 65 74 55 75 77 86 247 291
2022/20232.779 261 464 135 206 241 505 383 158 257 13 102 54
2023/20241.380 57 132 219 72 81 228 48 449 29 49 16 0
Totale 23.450